Sanofi invests $180 million equity in Owkin's artificial intelligence and federated learning to advance oncology pipeline

Sanofi announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional research milestone-based payments. Owkin, an artificial intelligence (AI) and precision medicine company, builds best-in-class predictive biomedical AI models and robust data sets.

from Breaking World Pharma News https://ift.tt/313k91c